| Year |
Citation |
Score |
| 2024 |
Li J, Ma A, Zhang R, Chen Y, Bolyard C, Zhao B, Wang C, Pich T, Li W, Sun N, Ma Q, Wen H, Clinton SK, Carson WE, Li Z, et al. Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy. Cancer Immunology, Immunotherapy : Cii. 73: 52. PMID 38349405 DOI: 10.1007/s00262-023-03603-3 |
0.34 |
|
| 2021 |
Li J, Bolyard C, Xin G, Li Z. Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy. Frontiers in Cell and Developmental Biology. 9: 747863. PMID 34988072 DOI: 10.3389/fcell.2021.747863 |
0.343 |
|
| 2021 |
Nair M, Bolyard C, Lee TJ, Kaur B, Yoo JY. Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy. Cancers. 13. PMID 34298774 DOI: 10.3390/cancers13143562 |
0.712 |
|
| 2020 |
Nair M, Khosla M, Otani Y, Yeh M, Park F, Shimizu T, Kang JM, Bolyard C, Yu JG, Kumar Banasavadi-Siddegowda Y, Lopez G, Kaur B, Pollock RE, Lee TJ, Old M, et al. Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation. Cancers. 12. PMID 32340193 DOI: 10.3390/Cancers12041040 |
0.731 |
|
| 2020 |
Thies KA, Hammer AM, Hildreth BE, Steck SA, Spehar JM, Kladney RD, Geisler JM, Das M, Russell LO, Bey JF, Bolyard CM, Pilarski R, Trimboli AJ, Cuitiño MC, Koivisto CS, et al. Stromal platelet-derived growth factor receptor-β signaling promotes breast cancer metastasis in the brain. Cancer Research. PMID 32327406 DOI: 10.1158/0008-5472.Can-19-3731 |
0.546 |
|
| 2019 |
Sette P, Amankulor N, Li A, Marzulli M, Leronni D, Zhang M, Goins WF, Kaur B, Bolyard C, Cripe TP, Yu J, Chiocca EA, Glorioso JC, Grandi P. GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival. Molecular Therapy Oncolytics. 15: 214-222. PMID 31890868 DOI: 10.1016/J.Omto.2019.10.005 |
0.567 |
|
| 2019 |
Hong B, Muili K, Bolyard C, Russell L, Lee TJ, Banasavadi-Siddegowda Y, Yoo JY, Yan Y, Ballester LY, Bockhorst KH, Kaur B. Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema. Molecular Therapy Oncolytics. 12: 93-102. PMID 30719499 DOI: 10.1016/J.Omto.2018.11.005 |
0.702 |
|
| 2019 |
Sizemore G, Hammer A, Thies K, Hildreth B, Russell L, Sizemore S, Trimboli A, Kladney R, Steck S, Das M, Bolyard C, Pilarski R, Schoenfield L, Otero J, Chakravarti A, et al. Abstract PD9-11: Platelet derived growth factor receptor-β signaling: A novel therapeutic target for breast cancer associated brain metastasis Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Pd9-11 |
0.413 |
|
| 2019 |
Thies K, Hammer A, Hildreth B, Russell L, Sizemore S, Trimboli A, Kladney R, Steck S, Das M, Bolyard C, Pilarski R, Cuitino M, Koivisto C, Schoenfield L, Otero J, et al. BSCI-11. STROMAL PLATELET DERIVED GROWTH FACTOR RECEPTOR-β (PDGFRβ) PROMOTES BREAST CANCER BRAIN METASTASIS Neuro-Oncology Advances. 1: i3-i3. DOI: 10.1093/noajnl/vdz014.009 |
0.559 |
|
| 2018 |
Thies KA, Hammer AM, Hildreth BE, Russell LO, Sizemore ST, Trimboli AJ, Kladney RD, Bolyard CM, Pilarski R, Schoenfield L, Otero J, Chakravarti A, Ringel M, Kaur B, Leone G, et al. Abstract 49: Stromal platelet derived growth factor receptor (PDGFRβ) signaling: A novel therapeutic target for breast cancer brain metastasis (BCBM) Tumor Biology. DOI: 10.1158/1538-7445.Am2018-49 |
0.424 |
|
| 2017 |
Dai HS, Griffin N, Bolyard C, Mao HC, Zhang J, Cripe TP, Suenaga T, Arase H, Nakano I, Chiocca EA, Kaur B, Yu J, Caligiuri MA. The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells. Immunity. 47: 159-170.e10. PMID 28723548 DOI: 10.1016/J.Immuni.2017.06.019 |
0.53 |
|
| 2017 |
Russell L, Bolyard C, Banasavadi-Siddegowda Y, Weiss A, Zhang J, Shakya R, Powell K, Kaur B. Sex as a biological variable in response to temozolomide. Neuro-Oncology. PMID 28379437 DOI: 10.1093/Neuonc/Nox040 |
0.371 |
|
| 2017 |
Russell L, Sprague A, Jaime-Ramirez AC, Bolyard C, Banasavadi-Siddegowda Y, Yoo J, Wang PY, Cripe T, Kaur B. Abstract 601: Oncolytic and immune effects of RAPTOR: a novel oncolytic Herpes Simplex Virus 1 expressing PTEN-L for brain tumor therapy Cancer Research. 77: 601-601. DOI: 10.1158/1538-7445.Am2017-601 |
0.636 |
|
| 2017 |
Saini U, Riley M, Dorayappan KD, Bolyard C, Kaur B, Zingarelli R, Konishi I, Kuppusamy P, Maxwell GL, Cohn DE, Selvendiran K. Abstract 5888: Tmem 205-mediated cisplatin resistance in ovarian clear cell carcinoma (OCCC) is overcome by herpes simplex virus (oHSV)/cisplatin combination therapy Cancer Research. 77: 5888-5888. DOI: 10.1158/1538-7445.Am2017-5888 |
0.554 |
|
| 2017 |
Thies KA, Hammer AM, Trimboli AJ, Hildreth BE, Russell LO, Bolyard CM, Kladney RD, Sizemore ST, Pilarski R, Schoenfield L, Otero J, Chakravarti A, Kaur B, Leone G, Ostrowski MC, et al. Abstract 3911: Stromal platelet derived growth factor receptor-beta (PDGFRbeta) promotes breast brain metastasis Cancer Research. 77: 3911-3911. DOI: 10.1158/1538-7445.Am2017-3911 |
0.393 |
|
| 2016 |
Bolyard CM, Meisen WH, Banasavadi-Siddegowda Y, Hardcastle J, Yoo JY, Wohleb ES, Wojton J, Yu JG, Dubin S, Khosla M, Xu B, Smith JG, Alvarez-Breckenridge C, Pow-Anpongkul P, Pichiorri F, et al. BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection- implications for Oncolytic Viral Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27852701 DOI: 10.1158/1078-0432.Ccr-16-1818 |
0.652 |
|
| 2016 |
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz B, Relation T, Yu JG, Lee TJ, Lotze MT, Zhang J, Croce CM, Yu J, Caligiuri MA, et al. Bortezomib treatment sensitizes oncolytic HSV-1 treated tumors to NK cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27390350 DOI: 10.1158/1078-0432.Ccr-16-1003 |
0.748 |
|
| 2016 |
Saini U, Naidu S, ElNaggar AC, Bid HK, Wallbillich JJ, Bixel K, Bolyard C, Suarez AA, Kaur B, Kuppusamy P, Hays J, Goodfellow PJ, Cohn DE, Selvendiran K. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target. Oncogene. PMID 27292260 DOI: 10.1038/Onc.2016.197 |
0.524 |
|
| 2016 |
Sizemore G, Mathur A, Thies K, Bolyard C, Sizemore S, Kladney R, Trimboli A, Kaur B, Leone G, Ostrowski M. Abstract C28: Platelet-derived growth factor receptor-β (PDGFRβ) in the breast metastatic tumor microenvironment Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-C28 |
0.524 |
|
| 2016 |
Saini U, Naidu S, ElNaggar AC, Bid HK, Wallbillich J, Wanner R, Bixel K, Riley M, Bolyard C, Suarez AA, Kaur B, Kuppusamy P, Hays J, Goodfellow P, Cohn DE, et al. Abstract LB-036: Elevated STAT3 expression in ovarian tumor ascites regulates invasion and metastasis: a promising therapeutic target Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-036 |
0.559 |
|
| 2016 |
Carbonell S, Yoo JY, Nallanagulagari T, Jaime-Ramirez AC, Bolyard C, Lee TJ, Zhang J, Croce C, Wu E, Aghi M, Kaur B. EXTH-33. OS2966 DRAMATICALLY ENHANCES PRECLINICAL EFFICACY OF ONCOLYTIC VIRUS THERAPY Neuro-Oncology. 18: vi66-vi66. DOI: 10.1093/Neuonc/Now212.277 |
0.574 |
|
| 2016 |
Weiss A, Koutras G, Bolyard C, Kaur B. 656. Effects of STAT3 Inhibition on the Innate Immune Response to OV Therapy Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)33464-5 |
0.659 |
|
| 2016 |
Sette P, Li A, Marzulli M, Leronni D, Zhang M, Goins W, Kaur B, Bolyard C, Amankulor N, Glorioso J, Grandi P. 520. Arming a Tumor Targeted Oncolytic HSV Vector with MMP9 for Enhanced Distribution and Killing Activity Molecular Therapy. 24: S207. DOI: 10.1016/S1525-0016(16)33329-9 |
0.59 |
|
| 2015 |
Meisen WH, Wohleb ES, Jaime-Ramirez AC, Bolyard C, Yoo JY, Russell L, Hardcastle J, Dubin S, Muili K, Yu J, Caligiuri M, Godbout J, Kaur B. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3274-85. PMID 25829396 DOI: 10.1158/1078-0432.Ccr-14-3118 |
0.799 |
|
| 2015 |
Li A, Marzulli M, Zhang M, Goins W, Kaur B, Bolyard C, Amankulor N, Leronni D, Sette P, Cohen J, Glorioso J, Grandi P. Abstract 3546: Arming a tumor targeted oncolytic herpes simplex sirus type 1 with matrix metalloproteinase 9 for enhanced vector distribution and killing activity Cancer Research. 75: 3546-3546. DOI: 10.1158/1538-7445.Am2015-3546 |
0.616 |
|
| 2015 |
Naidu S, Saini U, ElNaggar AC, Bid HK, Wanner R, Bixel K, Suarez AA, Bolyard C, Kaur B, Goodfellow PJ, Kuppusamy P, Cohn D, Selvendiran K. Abstract 1720: HO-3867, a selective inhibitor of stat3, suppress ovarian tumor growth and metastasis in human tissue culture and in an orthotopic mouse model Cancer Research. 75: 1720-1720. DOI: 10.1158/1538-7445.Am2015-1720 |
0.476 |
|
| 2015 |
Sette P, Li A, Marzulli M, Zhang M, Goins W, Kaur B, Bolyard C, Caligiuri M, Cripe T, Chiocca A, Amankulor N, Glorioso J, Grandi P. ATPS-26ONCOLYTIC VECTORS BASED ON HSV FOR TREATMENT OF GBM Neuro-Oncology. 17: v23.4-v23. DOI: 10.1093/Neuonc/Nov204.26 |
0.628 |
|
| 2014 |
Bolyard C, Yoo JY, Wang PY, Saini U, Rath KS, Cripe TP, Zhang J, Selvendiran K, Kaur B. Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6479-94. PMID 25294909 DOI: 10.1158/1078-0432.Ccr-14-0463 |
0.713 |
|
| 2014 |
Thorne AH, Meisen WH, Russell L, Yoo JY, Bolyard CM, Lathia JD, Rich J, Puduvalli VK, Mao H, Yu J, Caligiuri MA, Tridandapani S, Kaur B. Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1678-87. PMID 24895995 DOI: 10.1038/Mt.2014.101 |
0.765 |
|
| 2014 |
Yoo JY, Hurwitz BS, Bolyard C, Yu JG, Zhang J, Selvendiran K, Rath KS, He S, Bailey Z, Eaves D, Cripe TP, Parris DS, Caligiuri MA, Yu J, Old M, et al. Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3787-98. PMID 24815720 DOI: 10.1158/1078-0432.Ccr-14-0553 |
0.705 |
|
| 2014 |
Jaime-Ramirez A, Bolyard C, Meisen W, Dmitrieva N, Banasavadi-Siddegowda Y, Kaur B. Nt-12Impact Of Humanized Chondroitinase Abc On Ov Therapy For Intracranial Tumors. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou265.12 |
0.618 |
|
| 2014 |
Muili K, Bolyard C, Jaime-Ramirez C, Yoo JY, Kaur B. Et-40Oncolytic Virus Induced Hmgb1 Secretion And Its Impact On Tumor Angiogenesis Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou255.40 |
0.684 |
|
| 2014 |
Li A, Marzulli M, Mazzacurati L, Kaur B, Bolyard C, Cohen J, Goins W, Zhang M, Glorioso J, Grandi P. ET-34 * HIGHLY SELECTIVE HSV VIROTHERAPY FOR TREATMENT OF GLIOBLASTOMA Neuro-Oncology. 16: v87-v87. DOI: 10.1093/Neuonc/Nou255.34 |
0.554 |
|
| 2013 |
Okemoto K, Kasai K, Wagner B, Haseley A, Meisen H, Bolyard C, Mo X, Wehr A, Lehman A, Fernandez S, Kaur B, Chiocca EA. DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5952-9. PMID 24056786 DOI: 10.1158/1078-0432.CCR-12-3588 |
0.702 |
|
| 2013 |
Hurwitz BS, Yoo JY, Bolyard C, Yu J, Wojton J, Old M, Kaur B. Abstract 3312: Oncolytic HSV (34.5ENVE) sensitizes bortezomib-induced cancer cell killing through induction of RIP1 dependent necroptosis. Cancer Research. 73: 3312-3312. DOI: 10.1158/1538-7445.Am2013-3312 |
0.585 |
|
| 2013 |
Aaberg-Jessen C, Fogh L, Halle B, Jensen V, Brunner N, Kristensen BW, Abe T, Momii Y, Watanabe J, Morisaki I, Natsume A, Wakabayashi T, Fujiki M, Aldaz B, Fabius AWM, ... ... Bolyard C, et al. EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 15: iii37-iii61. DOI: 10.1093/Neuonc/Not176 |
0.4 |
|
| 2011 |
Büning H, Bolyard CM, Hallek M, Bartlett JS. Modification and labeling of AAV vector particles. Methods in Molecular Biology (Clifton, N.J.). 807: 273-300. PMID 22034035 DOI: 10.1007/978-1-61779-370-7_12 |
0.306 |
|
| Show low-probability matches. |